MEDTIDE (03880): China Securities Regulatory Commission issues record-filing notice on company's H-share full circulation application.
Ted Pharmaceutical (03880) issued an announcement that the company received a record notice from the China Securities Regulatory Commission on February 5, 2026 regarding the conversion and listing. According to the record notice, the relevant record of conversion and listing by the China Securities Regulatory Commission has been completed. If the company fails to complete the share conversion within 12 months from the issuance of the record notice, it shall update the record materials to the China Securities Regulatory Commission for further progress.
MEDTIDE (03880) announced that on February 5, 2026, the company received a filing notice from the China Securities Regulatory Commission regarding the conversion and listing. According to the filing notice, the relevant filing with the China Securities Regulatory Commission for the conversion and listing has been completed. If the company fails to complete the share conversion within 12 months from the date of the filing notice, any plans to continue the process must be updated with the China Securities Regulatory Commission.
As of the date of this announcement, the details of the implementation plan for the conversion and listing have not been finalized. The company will make further announcements regarding the progress of the conversion and listing in accordance with the listing rules and applicable laws and regulations.
Related Articles
The stock offering has become unconditional.
Burning cash to attack AI scares down Alphabet Inc. Class C (GOOGL.US) stock price, but ignites the semiconductor ecosystem: NVIDIA Corporation (NVDA.US) and Broadcom Inc. (AVGO.US) benefit the most?
HUANENG POWER (00902) completes issuance of 2 billion yuan in medium-term notes.
The stock offering has become unconditional.
Burning cash to attack AI scares down Alphabet Inc. Class C (GOOGL.US) stock price, but ignites the semiconductor ecosystem: NVIDIA Corporation (NVDA.US) and Broadcom Inc. (AVGO.US) benefit the most?
HUANENG POWER (00902) completes issuance of 2 billion yuan in medium-term notes.
